Filing Details

Accession Number:
0001179110-15-012500
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-08-24 08:46:01
Reporting Period:
2015-08-20
Filing Date:
2015-08-24
Accepted Time:
2015-08-24 08:46:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1159036 Halozyme Therapeutics Inc HALO Biological Products, (No Disgnostic Substances) (2836) 880488686
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1644348 Laurie Stelzer C/O Halozyme Therapeutics, Inc.
11388 Sorrento Valley Road
San Diego CA 92121
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-08-20 10,000 $17.24 10,000 No 4 P Indirect By trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By trust
Footnotes
  1. The price reported is the average weighted price. The shares were sold in multiple transactions at prices ranging from $17.21 to $17.25, inclusive. The reporting person undertakes to provide to the SEC, the issuer and any security holder full information regarding the number of shares and the prices at which the shares were purchased.
  2. The reporting person is co-trustee of the Gregory and Laureen Stelzer Living Trust.